DB
ELAN icon

Dmitry Balyasny’s Elanco Animal Health ELAN Stock Holding History

Dmitry Balyasny’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,086,098
Closed -$24.6M – 3052
2025
Q4 		$24.6M Sell
1,086,098
-964,189
-47% -$21M 0.03% 616
2025
Q3 		$41.3M Sell
2,050,287
-259,599
-11% -$4.35M 0.05% 423
2025
Q2 		$33M Buy
2,309,886
+596,444
+35% +$6.97M 0.05% 475
2025
Q1 		$18M Buy
1,713,442
+582,887
+52% +$6.59M 0.03% 646
2024
Q4 		$13.7M Sell
1,130,555
-3,615,922
-76% -$47.3M 0.02% 829
2024
Q3 		$69.7M Sell
4,746,477
-656,255
-12% -$9.14M 0.11% 209
2024
Q2 		$78M Buy
5,402,732
+1,526,720
+39% +$24.4M 0.14% 180
2024
Q1 		$63.1M Buy
3,876,012
+2,498,361
+181% +$39.1M 0.11% 235
2023
Q4 		$20.5M Sell
1,377,651
-2,438,335
-64% -$27.6M 0.04% 587
2023
Q3 		$42.9M Sell
3,815,986
-7,337,464
-66% -$85.2M 0.09% 309
2023
Q2 		$112M Buy
11,153,450
+7,067,923
+173% +$65.6M 0.25% 85
2023
Q1 		$38.4M Buy
4,085,527
+4,084,942
+698,281% +$48.2M 0.1% 297
2022
Q4 		$7.15K Sell
585
-2,838,682
-100% -$35.4M ﹤0.01% 2600
2022
Q3 		$35.2M Buy
+2,839,267
New +$49.6M 0.11% 242
2022
Q1 		– Sell
-1,675,190
Closed -$47.5M – 2558
2021
Q4 		$47.5M Buy
+1,675,190
New +$52.1M 0.16% 146
2021
Q3 		– Sell
-535,874
Closed -$18.6M – 2065
2021
Q2 		$18.6M Sell
535,874
-509,654
-49% -$16.8M 0.09% 312
2021
Q1 		$30.8M Sell
1,045,528
-337,671
-24% -$10.4M 0.15% 160
2020
Q4 		$42.4M Buy
+1,383,199
New +$42.2M 0.24% 102
2020
Q3 		– Sell
-1,105,352
Closed -$23.7M – 1369
2020
Q2 		$23.7M Buy
1,105,352
+825,387
+295% +$18.2M 0.21% 133
2020
Q1 		$6.27M Sell
279,965
-823,159
-75% -$22.5M 0.07% 350
2019
Q4 		$32.5M Buy
1,103,124
+820,853
+291% +$22.3M 0.19% 154
2019
Q3 		$7.51M Buy
282,271
+76,488
+37% +$2.29M 0.05% 470
2019
Q2 		$6.96M Sell
205,783
-137,490
-40% -$4.46M 0.04% 506
2019
Q1 		$11M Buy
343,273
+110,018
+47% +$3.39M 0.07% 362
2018
Q4 		$7.36M Buy
+233,255
New +$7.64M 0.05% 421

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Dmitry Balyasny's ELAN Position: Q1 2026 in Review

Dmitry Balyasny sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 1,086,098 shares — an estimated $24.6M sold.

Dmitry Balyasny first reported a position in ELAN in Q4 2018 and held it in 25 quarters. The position peaked at $112M in Q2 2023. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Dmitry Balyasny reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 1,086,098 Elanco Animal Health shares in Q1 2026, an estimated $24.6M.
  • Dmitry Balyasny first reported a position in Elanco Animal Health in Q4 2018 and held it in 25 quarters.
  • Dmitry Balyasny's Elanco Animal Health position peaked at $112M in Q2 2023.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.